WARREN, N.J. — Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, today announced that Nicholas J. Valeriani has been appointed to its board of directors. Since 2012, Mr. Valeriani, 58, has been the Chief Executive Officer of the Gary and Mary West Health Institute. Mr. Valeriani has announced plans to retire from the organization’s chief executive position, effective September 3, 2015, however he will remain on the Institute’s board of directors and will join the Gary and Mary West Health Policy Center’s board. Prior to joining West Health, Mr. Valeriani spent 34 years at Johnson & Johnson and served as a member of its executive committee.

“We are pleased to add Nick’s talents and deep experience to our board,” said Paul Thomas, Roka’s CEO and President. “Mr. Valeriani brings a unique perspective to our Board through his vast diagnostics expertise and track record of driving achievement of strategic and operating objectives. I, and the other members of the Roka Board, look forward to working with Nick as we continue to make progress toward our key initiatives and position Roka for accelerated long-term growth.”

Currently, Mr. Valeriani serves on the boards of directors of Robert Wood Johnson University Hospital, Edwards Lifesciences Corporation and the Center for Medical Interoperability. Mr. Valeriani has a master’s degree in business administration from Rutgers University, Graduate School of Management, and a bachelor’s degree in industrial engineering from Rutgers University, College of Engineering.

About Roka Bioscience

Roka Bioscience is a molecular diagnostics company focused on developing and commercializing advanced testing solutions for the food safety testing market. Our Atlas Detection Assays incorporate our advanced molecular technologies and are performed on our “sample-in, result-out” Atlas System that automates all aspects of molecular diagnostic testing on a single, integrated platform. The Atlas System and Detection Assays are designed to provide our customers with accurate and rapid test results with reduced labor costs and improved laboratory efficiencies. For more information, visit https://rokabio.com.